GlassScriptPhysician profile
Shaneabbas Raza
NPI 1376168955
$1,645.45
in general payments reported to CMS, 2019-2025
10 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $231 · 2023: $150 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $738 · Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $737.51 |
| Food and Beverage | $471.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $737.51 | 2025 | |
| Boston Scientific Corporation | $510.98 | 2021-2025 | Ams 700, Advance Xp, Moses |
| Coloplast Corp | $184.60 | 2021-2023 | Titan |
| Endo USA, INC. | $50.77 | 2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $42.96 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $31.75 | 2025 | |
| Laborie Medical Technologies Corp. | $28.86 | 2025 | |
| Photocure INC | $23.77 | 2025 | Cysview |
| Valencia Technologies Corporation | $20.63 | 2025 | Ecoin Device Kit |
| Abbvie INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaneabbas Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.